RAB7A Human

RAB7A, Member RAS Oncogene Family Human Recombinant
Cat. No.
BT10171
Source
Escherichia Coli.
Synonyms
RAB7A member RAS oncogene family, RAB7, ras-related protein Rab-7a, FLJ20819, PSN, CMT2B, PRO2706.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 90% as determined by SDS-PAGE.
Usage

THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

Shipped with Ice Packs
In Stock

Description

RAB7A produced in E.Coli is a single, non-glycosylated polypeptide chain containing 227 amino acids (1-207a.a.) and having a molecular mass of 25.6kDa.
RAB7A is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
RAB7A, a member of the Ras superfamily of small GTPases, plays a crucial role in regulating membrane trafficking. It interacts with the RIPL effector protein to control the movement of cargo from early to late endosomes and lysosomes. Additionally, RAB7A is involved in regulating the trafficking, degradation, and maturation of growth receptor endosomes, phagosomes, and autophagic vacuoles.
Description
Recombinant RAB7A protein, expressed in E. coli, is a single, non-glycosylated polypeptide chain with a molecular weight of 25.6 kDa. It consists of 227 amino acids, spanning from position 1 to 207, and includes a 20 amino acid His-tag at the N-terminus. The protein undergoes purification using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Formulation
The RAB7A protein is provided as a 0.5 mg/ml solution in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 1 mM DTT, 100 mM NaCl, and 30% glycerol.
Stability
For short-term storage (2-4 weeks), keep the protein solution at 4°C. For extended storage, freeze the solution at -20°C. To ensure stability during long-term storage, it is advisable to add a carrier protein such as HSA or BSA (0.1%). Avoid repeated freeze-thaw cycles to maintain protein integrity.
Purity
The purity of RAB7A protein is greater than 90%, as determined by SDS-PAGE analysis.
Synonyms
RAB7A member RAS oncogene family, RAB7, ras-related protein Rab-7a, FLJ20819, PSN, CMT2B, PRO2706.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MTSRKKVLLK VIILGDSGVG KTSLMNQYVN KKFSNQYKAT IGADFLTKEV MVDDRLVTMQ IWDTAGQERF QSLGVAFYRG ADCCVLVFDV TAPNTFKTLD SWRDEFLIQA SPRDPENFPF VVLGNKIDLE NRQVATKRAQ AWCYSKNNIP YFETSAKEAI
NVEQAFQTIA RNALKQETEV ELYNEFPEPI KLDKNDRAKA SAESCSC.

Product Science Overview

Introduction

RAB7A, a member of the RAS oncogene family, is a small GTPase that plays a crucial role in the regulation of vesicular transport. This protein is encoded by the RAB7A gene and is involved in various cellular processes, including endo-lysosomal trafficking, cell signaling, and lipid metabolism.

Gene and Protein Structure

The RAB7A gene is located on chromosome 3 and encodes a protein that consists of 207 amino acids. The protein belongs to the RAB family of small GTPases, which are known for their role in vesicle trafficking. RAB7A cycles between an active GTP-bound state and an inactive GDP-bound state, interacting with various effector proteins to regulate endosomal and lysosomal transport .

Biological Functions

RAB7A is primarily involved in the regulation of endo-lysosomal trafficking. It governs early-to-late endosomal maturation, endosome-lysosome transport, and endosomal positioning. The protein plays a central role in several cellular and physiological events, such as:

  • Growth-factor-mediated cell signaling
  • Nutrient uptake via nutrient transporters
  • Neurotrophin transport in neuronal axons
  • Lipid metabolism
Role in Disease

Mutations in the RAB7A gene have been associated with Charcot-Marie-Tooth disease type 2B (CMT2B), a hereditary neuropathy characterized by progressive muscle weakness and atrophy. These mutations often occur at highly conserved amino acid residues, leading to altered protein function and disease manifestation .

Research and Clinical Implications

RAB7A has been identified as a potential drug target and biomarker for various diseases, including cancer. Its role in vesicular trafficking and cell signaling makes it a critical player in tumorigenesis. Targeting RAB7A and its family members has become a focus of clinical research, with the aim of developing novel therapeutic strategies for cancer treatment .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.